BioSpace News Archive

Pharm Country

Helius Medical Technologies Completes Reverse Split of its Class A Common Stock

Helius Class A common stock will begin trading on a post-split basis at market open on January 23, 2018.

January 23, 2018
·
6 min read
Univercells Granted $2.9M to Develop Antibody Production Platform

This funding will enable the company to launch a program aimed at developing its innovative protein platform, paving the way for the cost-effective production of biosimilars.

January 23, 2018
·
3 min read
Business

Milken Institute Release: Health Leader Tanisha Carino, Ph.D. Takes Helm As New Executive Director of FasterCures

Tanisha Carino, Ph.D., the respected senior executive with more than two decades of experience in academia, government, and the private sector, is joining the Milken Institute as executive director of FasterCures.

January 23, 2018
·
3 min read
Business

LifeArc and Milner Therapeutics Institute Announce a New Partnership in Artificial Intelligence and Machine Learning for Target Discovery

LifeArc and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.

January 23, 2018
·
1 min read
Business

Genmab Announces 2017 Net Sales Figures for DARZALEX (Daratumumab)

Net sales of DARZALEX in 2017 totaled USD 1,242 million.

January 23, 2018
·
6 min read
Bio NC

Cell Microsystems Continues Momentum with $1.5M NIH Grant for Innovative Single-Cell RNA-Seq Platform

Cell Microsystems announced today it has been awarded a $1.5 million grant under the National Institutes of Health (NIH) SBIR program.

January 23, 2018
·
3 min read
Pharm Country

Insmed Announces Proposed Public Offering of Convertible Senior Notes

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

January 23, 2018
·
9 min read
Business

Cynata Executes MoU for Commercial Evaluation With Celularity

Cynata has entered into a MoU with Celularity, for the commercial evaluation of Cynata’s Cymerus production technology for use with Celularity’s therapeutic stem cell technologies.

January 23, 2018
·
6 min read
Biotech and Money Presents Biotech and Money/Medtech and Money World Congress on 5-6 February 2018

On 5-6 February, over 500 leading lights, emerging stars, C-suite executives, impactful investors and powerful stakeholders will attend the 4th annual Biotech and Money/Medtech and Money World Congress.

January 23, 2018
·
1 min read
Business

Arjo Announces Joint Partnership With Sony Mobile on Unique Tracking Solution Improving Healthcare Efficiency

The cloud-based solution aims to improve efficiency and quality of care by reducing time spent on locating critical equipment in healthcare environments.

January 23, 2018
·
3 min read